Gene therapy clinical trials, where do we go? An overview

Area of Science:

• Biotechnology
• Medical Science
• Genetics

Background:

• Gene therapy has evolved significantly since its inception.
• The field is marked by increasing market approvals and numerous ongoing clinical trials.
• Gene therapy holds substantial promise for treating various diseases.

Purpose of the Study:

• To review current and near-future gene therapy products.
• To analyze ten-year trends in gene therapy clinical trial strategies.
• To identify shifts in vectors, targets, and therapeutic areas.

Main Methods:

• Historical overview of gene therapy.
• Review of approved and emerging gene therapy products.
• Analysis of gene therapy clinical trial data over the past decade.

Main Results:

• Gene therapy is transitioning from rare genetic diseases to a primary focus on cancer treatment.
• Significant changes observed in gene therapy vectors, target cells, and delivery methods (ex-vivo/in-vivo).
• Cancer dominates the landscape of current gene therapy clinical trials.

Conclusions:

• The trajectory of gene therapy strategies, particularly in leading nations, indicates future product development directions.
• Gene therapy is a rapidly advancing field with expanding applications and a promising outlook.
• Continued analysis of strategic shifts is vital for stakeholders in pharmaceutical development and research.